Immunitas Therapeutics
Immuitas Therapeutics is a company using immunology for complex cancer treatment.
2
Funding Rounds
$97.0m
Money raised
Overview
Immuitas Therapeutics is a company using immunology for complex cancer treatment.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Immunitas Therapeutics has raised a total of $58m in funding over 2 rounds.
Key Insights:
- Immunitas Therapeutics Series B round, August 2021: $58m
- Immunitas Therapeutics Series A round November 2019: $39m
Immunitas Therapeutics Series B round, August 2021
$58m
Immunitas Therapeutics Series A round November 2019
$39m
Industries
Immunitas Therapeutics is active in the following industries: